Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesús García-Donás, Cristina Rodríguez‐Antona, Luis J. Leandro‐García et al.|The Lancet Oncology|2011Cited by 221